Page 2 - Expand Global Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

"The extraordinary impact of this pandemic demands that we move with unprecedented urgency, and that is what our teams have done by submitting this application for molnupiravir to the FDA."

Robert davisRidgeback biotherapeuticsAnthony fauciNational institute of allergyMedscape coronavirus resource centerDrug administrationCoronavirus resourceNational instituteInfectious diseasesRidgeback announce submissionEmergency use authorization applicationInvestigational oral antiviral medicineAntiviral molnupiravir reducedPositive interim analysisAnnounces supply agreementInvestigational oral antiviral candidate